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Yarrowia lipolyticaComplex I (NADH:ubiquinone oxidoreductase) has a central function in oxidative phosphorylation and
hence for efﬁcient ATP production in most prokaryotic and eukaryotic cells. This huge membrane protein
complex transfers electrons from NADH to ubiquinone and couples this exergonic redox reaction to
endergonic proton pumping across bioenergetic membranes. Although quinone reduction seems to be
critical for energy conversion, this part of the reaction is least understood. Here we summarize and discuss
experimental evidence indicating that complex I contains an extended ubiquinone binding pocket at the
interface of the 49-kDa and PSST subunits. Close to iron–sulfur cluster N2, the proposed immediate electron
donor for ubiquinone, a highly conserved tyrosine constitutes a critical element of the quinone reduction
site. A possible quinone exchange path leads from cluster N2 to the N-terminal β-sheet of the 49-kDa
subunit. We discuss the possible functions of a highly conserved HRGXE motif and a redox–Bohr group
associated with cluster N2. Resistance patterns observed with a large number of point mutations suggest that
all types of hydrophobic complex I inhibitors also act at the interface of the 49-kDa and the PSST subunit.
Finally, current controversies regarding the number of ubiquinone binding sites and the position of the site of
ubiquinone reduction are discussed.BQ, n-decylubiquinone;NADH,
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Mitochondrial complex I (NADH:ubiquinone oxidoreductase) is a
huge multisubunit membrane protein and the least understood
component of the respiratory chain [1–5]. It is composed of at least 40
protein subunits with a total mass of ∼1 MDa [6,7]. Fourteen of these
subunits are conserved between eukaryotes and prokaryotes [8] and are
sufﬁcient to couple the catalyzed redox reaction to proton translocation
across thebioenergeticmembrane. In contrast toother respiratory chain
complexes, the crystal structure of complete complex I has not been
solved yet. However, single particle electron microscopy revealed that
complex I has an L-shaped overall structure both in eukaryotes and
prokaryotes [9–17]. The hydrophobicmembrane domain of the enzyme
is embedded in the mitochondrial membrane, whereas the hydrophilic
peripheral domain protrudes into the mitochondrial matrix. The
peripheral domain contains all known redox centers, a non-covalently
bound FMN and 8–9 iron–sulfur clusters [18–22].In 2006, Sazanov and coworkers succeeded in solving the X-ray
structure of the peripheral domain of complex I from Thermus
thermophilus at 3.3 Å resolution [22]. The Y-shaped fragment revealed
the spatial arrangement of the seven central hydrophilic subunits as well
as the locations of all knownredox centers of complex I. Seven iron–sulfur
clusters (N1b, N2, N3, N4, N5, N6a undN6b) form an approximately 95 Å
long chain of redox centers. This chain starts with iron–sulfur cluster N3
next to the FMNmolecule in the 51-kDa subunit and ends at iron–sulfur
clusterN2 in the PSST subunit next to a broad cavity at the interface of the
PSST and the 49-kDa subunit (the bovine nomenclature for homologous
complex I subunits will be used throughout).
No redox centers were found in the membrane domain of complex
I [23]. However, this part of the enzyme must harbor the proton
translocating device(s). The membrane domain subunits ND2, ND4
and ND5 are homologous to Na+/H+-antiporters [24] and therefore
were suggested to be involved in proton translocation [25–28].
Interestingly, subunits ND4 and ND5 were found to be located at
the distal end of the membrane domain [29–32] at a considerable
distance from the peripheral domain and thus to be well separated
from all known redox centers. This strongly suggests that long range
conformational changes are involved in driving vectorial proton
translocation by complex I, as will be discussed in the following.
2. Energy conversion and quinone reduction
The molecular mechanism by which complex I couples redox
reactions to vectorial proton pumping is unknown. Several constrains
Table 1
Functionally important residues of the 49-kDa and the PSST subunit near iron–sulfur
cluster N2 of complex I.
Amino
acid
Effect on
catalytic
activitya
Effect on inhibitor bindingb Function
DQA
(type A)
Rotenone
(type B)
C12E8
(type C)
49-kDa subunit
Y144 ++ +++ ++ + Quinoneand inhibitor binding
H95 +++ n.d. n.d. n.d. Quinone access path
H226 + − − − Redox–Bohr group of N2
D143 ++ ++ +++ − Ex-Ni ligand
S146 − ++ + − Ex-Ni ligand
V460 ++ ++ +++ n.d. Ex-Ni ligand
E463 ++ + − − Ex-Ni ligand
M188 − + ++ − Inhibitor binding
F203 + ++ ++ ++ Inhibitor binding
F207 + + ++ ++ Inhibitor binding
R224 − − − + Inhibitor binding
L225 − − − + Inhibitor binding
K407 − ++ − − Inhibitor binding
D458 ++ +++ ++ − Inhibitor binding
H120 + − − n.d. HRGXE motif
R121 +++ n.d. n.d. n.d. HRGXE motif
G122 − − − n.d. HRGXE motif
E124 ++ − − n.d. HRGXE motif
R141 ++ + + n.d. N2 interaction
PSST subunit
C85 n.d. n.d. n.d. n.d. N2 ligands
C86 n.d. n.d. n.d. n.d. N2 ligands
C150 n.d. n.d. n.d. n.d. N2 ligands
C180 n.d. n.d. n.d. n.d. N2 ligands
V88 + + − + Unknown
M91 ++ +++ +++ + Unknown
a +, ++ and +++ indicate increasing effect on NADH:ubiquinone oxidoreductase
activity by mutations of the respective residue [49,59,62,63,108];−, no effect; n.d., not
determined.
b +, ++ and +++ indicate overall strength of effect on inhibitor binding by
mutations of the respective residue [49,62,63,108]; −, no effect.
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across the bioenergetic membrane [33–35], (ii) the coupling between
redox reaction and proton translocation is tight and reversible [36],
and (iii) all known redox centers are located in the peripheral domain
[23,37]. Over the years, many different mechanisms were proposed
([26,38–46]; see [47] for a compilation of earlier proposals); however,
most of them were disproven based on newer results. As predicted
from electron transfer theory [48], electron transfer from NADH to N2
has been shown to be very fast [49]. It takes less than 100 µs for an
electron to travel all the way from NADH to iron–sulfur cluster N2;
therefore it seems unlikely that this part of the reaction is coupled to
proton translocation. As will be discussed later, energy transduction
involving a redox–Bohr group associated with iron–sulfur cluster N2
was essentially ruled out, since a mutation that abolished pH
dependence of the redox midpoint potential of N2 did not alter the
proton pumping capacity of the enzyme [50]. Also, a Q-cycle type
mechanism can be excluded, since in analogy to complex III it would
require redox centers in the membrane domain of the enzyme; in
addition, no evidence for reductant-induced oxidation of ubiquinol
was found [51]. Taken together, the mechanism of redox linked
proton translocation of complex I most likely involves long range
conformational changes in the membrane domain coupled to and
driven by quinone reduction in the peripheral domain [1,3,26,45].
3. Design of the quinone binding site
It has been suggested earlier that the quinone binding pocket of
complex I is formed by the PSST and the 49-kDa subunit [52,53] that
are evolutionary related to the small and large subunits of water-
soluble [NiFe]-hydrogenases [54,55]. This proposal had been based on
mutagenesis studies showing that many functionally critical residues
are located in this part of the enzyme and that mutations which target
the former [NiFe]-site confer resistance towards complex I inhibitors
which act at the quinone binding site [52,56–60]. In addition,
photoafﬁnity labeling studies suggested that the PSST subunit forms
part of the quinone and inhibitor binding pocket of complex I [61].
Further support came from more recent mutagenesis ([62,63];
Table 1) and photoafﬁnity labeling studies [64] and the crystal
structure of the hydrophilic domain of complex I from T. thermophilus
[22]. The structure shows a chain of iron–sulfur clusters leading from
the FMN cofactor to a broad cavity formed by the PSST and the 49-kDa
subunit, which is believed to comprise the quinone binding site.
For the ﬁrst time, the partial X-ray structure allowed structure
based mutagenesis studies of complex I. As summarized in Table 1, a
large number of point mutations was introduced in complex I from
the yeast Yarrowia lipolytica in order to systematically explore the
entire surface of the proposed quinone and inhibitor binding pocket
[65]. Importantly, exchanges in this part of the enzyme had hardly any
effect on the stability or assembly of complex I; therefore, this
mutagenesis study allowed the identiﬁcation of functional domains
within the large quinone binding cavity. Most residues that are critical
for complex I activity form a path reaching from the N-terminal three
stranded β-sheet into the cavity towards iron–sulfur cluster N2.
Residues located outside this area are less critical for complex I
activity. Interestingly, also residues located deeper in the cavity,
where the PSST and the 49-kDa subunits form a narrow crevice, can be
exchanged without a major effect on complex I activity. These
functional domains will be discussed in more detail below.
3.1. Quinone binding domain
Amino acid residues that are critical for complex I activity are
found in close proximity to iron–sulfur cluster N2 (Fig. 1). Tyrosine-
144 (Y. lipolytica numbering will be used throughout) and valine-460
in the 49-kDa subunit are prime candidates to function in quinone
binding and/or reduction [65]. The distance between the highlyconserved tyrosine-144 and cluster N2 is only 6-8 Å and all exchanges
introduced at this position, including the exchange to phenylalanine,
speciﬁcally removing the hydroxyl group and retaining its aromatic
phenyl-moiety, cause an almost complete loss of DBQ reductase activity
of complex I [66]. Consistentwith the proximal position of tyrosine-144
to this redox center, non-conservative exchanges severely affect the EPR
spectrum of cluster N2 in mitochondrial membranes. In contrast, an
unchanged N2 signal was recorded from mitochondrial membranes as
well as from the puriﬁed enzyme carrying the moderate exchange
Y144F. This suggests that the loss of activity in the Y144F mutant
resulted from direct interference with quinone binding and/or
reduction, rather than from a general perturbation of the environment
of iron–sulfur cluster N2. To further test this interpretation, the afﬁnity
of the enzyme for different quinone derivativeswas assessed [66]. Since
all Y144 mutants exhibited very low DBQ reductase activities, this
parameter could not be determined for this compound carrying an
n-decyl side chain. The physiological substrate Q9 with a side chain of
nine isoprene units is too hydrophobic to be used in in vitro assays.
However, with the short chain analogs Q1 and Q2 carrying side chains of
one or two isoprene units, unchanged or only moderately reduced Vmax
values were found in mutants Y144F and Y144W. In mutant Y144F
ubiquinone reductase activity with both substrates was coupled to
proton pumping [66] indicating that Q1 and Q2 were indeed reduced at
the physiological ubiquinone reduction site. However, the apparent Km
values for Q2 and evenmore so for Q1were drastically increased and the
activity showed a pronounced resistance to the complex I inhibitors
decyl-quinazoline-amine (DQA) and rotenone [66].
Loss of electron transfer activity fromNADH toDBQbutnot toQ1 and
Q2 in the Y144F and Y144W mutants demonstrated that the quinone
side chain is speciﬁcally recognized by complex I, as previously
suggested [67]. On the other hand, increased Km values and pronounced
Fig. 1. Overview of the quinone and inhibitor binding cavity. The cavity is located next
to iron–sulfur cluster N2 (in black) at the interface of the 49-kDa (in blue-gray) and the
PSST subunits (in cyan-green). The color gradient indicates the position of amino acid
residues which are critical (red), less critical (yellow and green) and not critical (blue)
for complex I activity. The position of tyrosine-144 and histidine-226 is indicated. The
arrow indicates a possible access path for the quinone substrate (Q). The location of
the HRGXE motif is highlighted.
Fig. 2. Spatial arrangement of the HRGXE motif which reaches from iron–sulfur cluster
N2 to the 30-kDa subunit. Amino acid residues from the motif are highlighted in pink
and are shown in stick representation. Additional amino acid residues which interact
with those of the motif are also shown in stick representation. Residues are labeled
according to Y. lipolytica numbering. Note that arginine-121 from the 49-kDa subunit is
changed to a threonine and threonine-122 from the PSST subunit is changed to an
arginine in T. thermophilus, thereby restoring the arginine-threonine hydrogen bonding.
Numbers indicate the distances between atoms in Ångströms. For a rough orientation
tyrosine 144 is highlighted in gray stick representation. Iron–sulfur cluster N2 is shown
as a space ﬁll model, the PSST, 49-kDa and 30-kDa subunits are shown in schematic
representation. Intensive interaction of the HRGXE motif with neighboring residues
indicates that this motif has a structural function. The ﬁgure was generated from the
crystal structure of the hydrophilic domain of complex I from T. thermophilus (PDB ID:
2FUG) by using the PyMOL program.
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tions at the ubiquinone reduction site upon exchange of tyrosine-144.
Although it has to be stressed that Km is not identical to the Kd, this
parameter does provide a reasonable assessment for the afﬁnity to the
substrate, if the Vmax values are in a similar range. Inmutants Y144F and
Y144W π–π interactions between the ring systems of the side chain and
the quinone head group remain possible, but interactions involving the
hydroxyl group of the tyrosine are abolished. In this case the afﬁnity of
thequinonebinding site to the substrate reliesmore on thequinone side
chain [66]. We conclude from these results that the hydroxyl group of
tyrosine-144 is involved in binding of the quinone head group. The
amino acid residues which speciﬁcally interact with the isoprene side
chain of the quinones remain to be identiﬁed.
3.2. Quinone exchange domain
The critical role of tyrosine-144 for ubiquinone reductase activity
is not unexpected considering its close proximity to iron–sulfur
cluster N2. However, probing the quinone binding pocket in an
extended mutagenesis study revealed that more distant residues like
histidine-95 in the 49-kDa subunit that is located at least 16 Å (edge-
to-edge distance) away from cluster N2 are essential for complex I
activity [65]. An ubiquinone headgroup at this position would be too
far away for efﬁcient electron tunneling from cluster N2 [68]. It rather
seems that histidine-95 and other residues within the N-terminal
β-sheet of the 49-kDa subunit like alanine-94 and arginine-99, located
in the loop between the β-sheet strands, form an access path for the
quinone substrate. Mutations in this region seem to cause loss of
activity by interfering with substrate exchange. It is tempting to
speculate that this path extends further down to themembrane phase
via histidine-91 in the 49-kDa subunit and aspartate-99, aspartate-
115, aspartate-136 and glutamate-140 in the PSST subunit, since these
residues were also found to be critical for complex I activity
[62,69,70]. However, the location of these residues in relation to
iron–sulfur cluster N2 and the quinone binding pocket is unknown,
since these residues are not resolved in the X-ray structure of the
hydrophilic fragment of complex I from T. thermophilus.
It has also been proposed earlier that the highly conserved HRGXE
motif (Fig. 2) in the 49-kDa subunit may form part of the quinonebinding domain of complex I [58]. The crystal structure of the peripheral
arm from T. thermophilus [22] revealed that these residues are not
located within the quinone binding pocket. Yet, they are positioned not
far away from iron–sulfur clusterN2, suggestinga critical role in forming
the fold around the catalytic site. In fact, mutagenesis of the HRGXE
motif revealed that these residues and especially glutamate-124 are
rather critical for complex I assembly and seem to have an important
structural role (unpublished observations).
As a crystal structure of holo-complex I is still missing, the subunits
forming the contact sites between the hydrophilic and hydrophobic
arms have to be inferred from biochemical data. The PSST and 49-kDa
subunits were both shown to physically interact with the hydropho-
bic ND3 subunit by cross-linking experiments [71]. Also mutations in
the extended extramembraneous domains of the ND1 subunit
interfered with the assembly of peripheral subunits with the mem-
brane domain of complex I, suggesting a critical bridging function of
this subunit [72]. In addition, several lines of evidence indicate that
subunit ND1 is involved in inhibitor and ubiquinone binding [73–82].
Concomitant inhibitor labeling of subunits ND1/49-kDa [80] and ND1/
PSST [78] suggests that the ND1 subunit forms the access path
towards the ubiquinone reduction site at the interface of the 49-kDa
and PSST subunits.3.3. Iron–sulfur cluster N2
An essential component of the quinone binding site is iron–sulfur
cluster N2. It is a tetranuclear cluster with four cysteine-ligands in the
PSST subunit and resides close to the interface to the 49-kDa subunit.
Its binding motif is quite special due to the participation of two
cysteines which are immediate neighbors in the primary structure of
the subunit [83]. It is generally accepted that iron–sulfur cluster N2 is
located at the end of a wire of redox centers transferring electrons
from the ﬂavin site to quinone. A direct interaction of N2 with the
quinone substrate is supported by a paramagnetic interaction of
semiquinone radicals with iron–sulfur cluster N2 that can be detected
by EPR spectroscopy [19,84].
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higher redox midpoint potential when compared to the other iron–
sulfur clusters, making it the electron sink of complex I [85]. This
feature results in very fast reduction of cluster N2 within 90 µs after
electron injection into the chain fromNADH [49]. Moreover, the redox
midpoint potential of cluster N2 shows pronounced pH dependence,
becoming more positive with decreasing pH [85]. Based on these
special properties, iron–sulfur cluster N2 has been suggested to play a
key role in coupling of the redox reactions to the translocation of
protons across the membrane [39,42].
The pH dependence of the N2 redox potential, a phenomenon
called redox–Bohr effect, can be explained by the inﬂuence of one or
more nearby protonable groups affecting the electron afﬁnity of the
cluster. Based on results from site directed mutagenesis and redox
titrations monitored by EPR spectroscopy, histidine-226 (hisitidine-
169 in T. thermophilus) in the 49-kDa subunit was identiﬁed as the
major redox–Bohr group modulating the redox midpoint potential of
cluster N2 [50]. The exchange of this histidine to methionine shifted
the midpoint potential at neutral pH from−140 mV to−220 mV and
abolished its pH dependence completely. Strikingly, the mutation had
no signiﬁcant effect on catalytic activity and the enzyme complex still
pumped protons with an unchanged stoichiometry of 4 H+/2e−. This
indicates that the redox–Bohr effect of cluster N2 is most likely not
involved in proton pumping. Rather, these observations strongly
suggest that the release of the energy driving proton transfer across
themembrane is linked to the redox chemistry of the quinone and not
to the electron transfer reactions upstream.
3.4. Binding of quinone-like inhibitors
In analogy to studies on complex III (cytochrome bc1 complex),
numerous inhibitor studies with various complex I inhibitors were
performed in order to determine the number and the location of the
quinone binding site(s) in complex I. More than 60 families of natural
and synthetic complex I inhibitors were described [86–92]. Most of
these compounds are hydrophobic and inhibit the NADH:ubiquinone
oxidoreductase activity of complex I; however, they interfere neither
with the NADH:ferricyanide oxidoreductase activity [93] nor with the
reduction of EPR detectable iron–sulfur clusters [94]. Thus it was
concluded that they act at the quinone binding site of complex I.
Based on steady state kinetics, Friedrich and coworkers grouped 12
of these complex I inhibitors into two classes [94]. Class I inhibitors
(piericidin A, fenpyroximate and others) act in a partially competitive
manner to Q2 on complex I and competitively on the related quinone
binding site of bacterial glucose:ubiquinoneoxidoreductase. In contrast,
class II inhibitors (rotenone and others) act non-competitively on
complex I and do not inhibit glucose:ubiquinone oxidoreductase. Based
on an extensive literature survey, Degli Esposti grouped the inhibitors of
complex I into three categories [86,95], type A, B and C. In this
classiﬁcation, type A and type B largely correspond to Friedrich's class I
and class II, respectively. Type C inhibitors, represented by capsaicins
and their synthetic analogues like CC44 [96], form a distinct group. The
n-alkyl-polyoxyethylene-ether detergent C12E9 (Thesit) was proposed
to be a type C inhibitor as well, since it was found to bind competitively
to CC44 [92].
The establishment of various types or classes of complex I inhibitors
led to the concept that these inhibitors bind to different parts of the
enzyme corresponding to several distinct quinone reaction sites
[86,95,97]. This concept was in agreement with various photoafﬁnity
labeling studies which as a whole seemed to suggest that different
inhibitor binding sites reside in different complex I subunits. Among
these subunits PSST [61,98,99], 49-kDa [64,80,99], ND1 [73–80] and
ND5 [99] were proposed to contain inhibitor binding site(s). However,
photoafﬁnity labeling studies are prone to generate false positive
results, sincehydrophobic inhibitors have a preference to associatewith
hydrophobic domains and thus predominantly label hydrophobicsubunits. In addition, in some studies the photo-labile group was
attached far away from the toxophoric moiety at rather ﬂexible parts of
the inhibitor. While this design can avoid a decrease in afﬁnity, it also
makes the labeling of protein regions not involved in inhibitor binding
more likely thereby further hampering unambiguous interpretation of
the results, as has been criticized by Miyoshi and coworkers [64,80].
In addition, various mutagenesis studies suggested that the
inhibitor binding pocket of complex I was located in the ND1 subunit
[82,100–102], the ND4 subunit [100,103] and/or the ND6 subunit
[104–106]. However, it cannot be excluded that these mutations may
have caused long range effects on the quinone binding pocket at the
interface between the PSST and the 49-kDa subunit, especially since a
tight and reversible coupling between the quinone reduction site near
iron–sulfur cluster N2 and subunits of the membrane domain has to
be assumed to be fundamental for proton translocation [2,3,45].
In contrast, direct competition binding assays revealed that all
three types of complex I inhibitors bind to partially overlapping
binding sites within a large common pocket [91]. According to this
study, the binding site for type A inhibitors overlaps with that for type
B inhibitors, and the binding site for type C inhibitors overlaps with
that for type B inhibitors but not with that for type A inhibitors.
However, also this interpretation of the competition binding assays
was challenged and it was suggested that the apparent competitive
behavior of inhibitors may have been caused by negative allosteric
effects, i.e. that the binding of one inhibitor to one binding site
induced structural changes which prevent the binding of another
inhibitor to a remote binding site [64,78,107–109]. Alternatively, it
was speculated that different inhibitors might inhibit different steps
in the catalytic cycle and therefore compete functionally, but not
spatially [110]. However, results from extensive mutagenesis studies
on the quinone and inhibitor binding pocket indicate that the binding
sites for the three types of complex I inhibitors indeed overlap
spatially [65,111]. In these studies many mutants conferring resis-
tance were identiﬁed which, depending on the inhibitor tested,
cluster in well deﬁned and partially overlapping regions of the large
putative quinone and inhibitor binding cavity (Fig. 1). Mutants with
effects on type A (DQA [91]) and type B (rotenone) inhibitors were
found in a subdomain corresponding to the former [NiFe] site in
homologous hydrogenases, whereby the type A inhibitor DQA seems
to bind deeper into this domain. Mutants with effects on the type C
inhibitor (C12E8; [92,96]) were exclusively found in a narrow crevice
which seems not to be important for complex I activity. Not
surprisingly, changing more exposed residues located in-between
the putative binding sites of type A, B and C inhibitors affect inhibition
by all three inhibitors. These results strongly support the concept that
different inhibitor types bind to different but partially overlapping
binding sites within a single large quinone binding pocket as proposed
by Okun and coworkers [91]. In addition, the mutagenesis studies also
indicate the approximate location of the binding sites of different
complex I inhibitor classes within the large quinone and inhibitor
binding cavity at the interface of the 49-kDa and the PSST subunit
(Fig. 1).
4. Controversies
There is general agreement that in complex I ubiquinone is
reduced by electrons donated from iron–sulfur cluster N2 at the
interface of the PSST and the 49-kDa subunit. In contrast, the presence
of multiple ubiquinone interaction sites and the position of cluster N2
and the associated ubiquinone reduction site within holo-complex I
remain a matter of disagreement.
4.1. Additional quinone binding sites in complex I?
As mentioned above, in bovine submitochondrial particles (SMP)
semiquinone radicals related to complex I have been monitored by
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discriminate between a slow (SQNs) and a fast (SQNf) relaxing species
[84,112–115]. In contrast to the SQNs signal, the SQNf signal is
observed exclusively in the presence of a membrane potential,
suggesting a key function in energy conservation. Based on dipolar
interactions, a distance of SQNf to cluster N2 of 12 Å was calculated
[112]. The different properties of SQNf and SQNs were taken as an
indication for the presence of two spatially and functionally different
ubiquinone interaction sites in complex I [19,38,42,114,116]. In a
hypothetical reaction mechanism, SQNf was proposed to function as
an electron carrier between cluster N2 and a distantly located
substrate ubiquinone corresponding to the SQNs species [42].
However, the existence of two distinct EPR detectable semiquinone
species does not necessarily indicate the presence of two distinct
ubiquinone reduction sites, since the sum of the spin concentrations
was never found to exceed one per complex I ([117]; Zwicker,
unpublished data). In addition, fully active complex I from Y. lipolytica
and E. coli was shown to contain only 0.2–1 quinone molecules per
complex I [45,49,118]. Therefore it seems quite possible that the two
spectroscopically distinct semiquinone species represent subpopula-
tions of one and the same molecule in conformationally different
states, changing the distance or other parameters relevant for the
coupling between the two paramagnetic species, rather than two
quinone molecules that simultaneously bind at two spatially
separated quinone binding sites.
Conserved sequence motives for putative ubiquinone binding sites
were identiﬁed in subunits ND4 and ND5 of the membrane arm [119],
and ND4 was labeled with an azido-ubiquinone derivative [120].
However, similar labeling experiments with respiratory complex III
have turned out to be misleading because of unspeciﬁc binding [121].
Moreover, a detailed site directed mutagenesis study rendered a
function of the ND4 subunit in ubiquinone binding highly unlikely
[122]. Notably, the ND4 and ND5 subunits are located in the distal part
of the membrane domain [29–32] and therefore around 100 Å away
from iron–sulfur cluster N2, the proposed immediate electron donor
to quinone.
It should be mentioned that photoafﬁnity labeling studies with
quinone analogues and mutagenesis studies showing changed
quinone reduction kinetics suggest that also the ND1 [82,100–102],
the ND4 [100,103] the ND6 subunit [104–106] and even the mammal-
speciﬁc B9 subunit [123,124] may contribute to the quinone binding
site. However, as discussed above, photoafﬁnity labeling studies are
prone to give false positive results and the described effects of
mutations are probably due to long range structural changes.
Finally, all classical complex I inhibitors were shown to bind to
only one extended binding pocket with overlapping binding sites,
arguing strongly against the presence of a second yet undetected
ubiquinone reduction site [92,111]. Inhibitor labeling of the ND1
subunit in addition to the 49-kDa/PSST subunits [78,80] does not
contradict this ﬁnding but probably identiﬁes a functional unit that
comprises the hydrophilic subunits as the catalytically active part and
the ND1 subunit as the membrane anchor guiding hydrophobic
molecules to the active site.
Although unlikely, at this stage additional ubiquinone interaction
sites in complex I cannot be ruled out entirely. However, in our view
there is also no compelling evidence forcing us to consider a more
complicated situation than that of a single functional site where
ubiquinone reduction couples to proton translocation via long range
conformational changes.
4.2. An ubiquinone reduction site spatially separated from the
membrane phase?
Ubiquinone is a very hydrophobic molecule. Thus, a priori it seems
obvious that its binding site should be located in a hydrophobic,
membrane intrinsic environment. However, neither the 49-kDasubunit nor the PSST subunit are hydrophobic proteins and it is
evident from the X-ray structure of the peripheral arm that the
immediate electron donor to ubiquinone, cluster N2, is located in the
peripheral arm outside of the membrane phase.
The structure of the holo-enzyme complex from different organ-
isms has been determined by electron microscopy (reviewed in [3]).
Morgan and Sazanov have manually docked the X-ray structure of the
peripheral arm fragment of T. thermophilus into a 35 Å resolution
electron microscopic structure of E. coli complex I [16]. In this model
the 49-kDa and PSST subunits were placed in direct contact with the
membrane and appeared to be even partially immersed in the
hydrophobic phase. Then cluster N2 would reside at a distance of
approximately 10 Å above the membrane surface. However, the
rather featureless 3D model of the bacterial holo-complex provides
little structural constraints that would argue for this particular
orientation to be the only one possible to accommodate the peripheral
arm X-ray model. At a resolution of up to 16.5 Å the electron
microscopic structure of complex I from Y. lipolytica allowed to
identify six distinct domains in the peripheral arm [15]. It should be
noted that this model was obtained from deep-stained particles.
Although this negative stain technique minimizes ‘ﬂattening’ of the
specimen, some structural distortion by this effect cannot be fully
excluded. Structural analysis of a subcomplex unambiguously showed
domain 1 at the distal end of the peripheral arm to contain the 51-kDa
subunit and 24-kDa subunit [37,125]. Using this assignment as an
anchor point still allowed for ﬁve different ﬁts of the X-ray structure of
the peripheral arm fragment into the electron microscopic structure
of complex I from Y. lipolytica [37]. In contrast to the model of Morgan
and Sazanov none of the possible ﬁts indicated a distance of cluster N2
to the membrane surface shorter than 35 Å. This result is in good
agreement with previous electron microscopic studies of immunola-
beled complex I which indicated a position of the 49-kDa subunit in
the distal part of the peripheral arm [126]. Recently, a three domain
substructure of the peripheral arm was resolved in the electron
microscopic structure of complex I from the eubacterium Aquifex
aeolicus [17]. With the assignment of the 51- and 24-kDa subunits to
the distal domain 1, the ubiquinone bindingmodule could correspond
to either of the two remaining domains, both of which were found
clearly separated from the membrane phase. Again, the closest
possible distance of cluster N2 to the membrane was estimated to
be around 30 Å [17].
Determination of the orientation of the peripheral arm and the
exact distance of cluster N2 to the membrane will only be possible
with an X-ray structure of the complete enzyme complex. However, in
our view there is compelling evidence that the ubiquinone binding
site projects into the peripheral arm and ubiquinone reduction occurs
well outside of the membrane phase. This architecture led us to
suggest a hydrophobic ramp that could include extramembraneous
loops or domains of hydrophobic ND subunits as suggested by cross-
linking experiments between the hydrophobic ND3 subunit with the
PSST and the 49-kDa subunits [71] and combined inhibitor labeling of
the PSST, 49-kDa and ND1 subunits [78,80].
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